Company news
Infield Minerals Corp news in 2019
Infield Minerals Corp's news releases, calls and decks from 2019, newest first.
InMed Receives Clinical Trial Application Approval for INM-755, a Rare Cannabinoid Formulation Under Development for the Treatment of Epidermolysis Bullosa
December 9, 2019
Edison issues update on InMed Pharmaceuticals
November 18, 2019
InMed Pharmaceuticals to Present at the Cowen Conference
November 11, 2019
InMed Pharmaceuticals Reports First Quarter Fiscal 2020 Financial Results and Provides R&D and Business Update
November 8, 2019
InMed Submits Clinical Trial Application to Evaluate INM-755 in Phase 1 Trial
November 5, 2019
InMed Pharmaceuticals to Report First Quarter Fiscal 2020 Financial Results and Business Update on November 8, 2019
November 4, 2019
InMed Pharmaceuticals to Present at the BIO Investor Forum
October 18, 2019
Edison Issues Update on InMed Pharmaceuticals (IN)
September 26, 2019
InMed Pharmaceuticals to Present at the Regulatory Affairs Professionals Society's annual conference
September 23, 2019
InMed Pharmaceuticals Reports Fourth Quarter and Full Year Fiscal 2019 Financial Results and Provides R&D and Business Update
September 19, 2019
InMed Pharmaceuticals to Report Fourth Quarter, and Full Year Fiscal 2019 Financial Results and Business Update on September 19, 2019
September 12, 2019
InMed Pharmaceuticals to Present at the H.C. Wainwright 21st Annual Global Investment Conference
September 3, 2019
InMed Pharmaceuticals to Attend the 2nd Annual International Cannabinoid-Derived Pharmaceuticals Summit
August 29, 2019
InMed Pharmaceuticals Appoints Bruce S. Colwill, CPA, CA as Chief Financial Officer and Announces other Leadership Changes
August 2, 2019
InMed Pharmaceuticals Appoints Catherine Sazdanoff to Board of Directors
July 2, 2019
InMed Pharmaceuticals Reports Third Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update
May 15, 2019
InMed Pharmaceuticals to Report Third Quarter Fiscal 2019 Financial Results and Business Update on May 15, 2019
May 8, 2019
InMed Continues to Strengthen IP Portfolio for its Biosynthesis Platform Technology
March 18, 2019
InMed Pharmaceuticals Announces Transition to a Single Cannabinoid Investigational Drug Candidate - INM-755 - for its Epidermolysis Bullosa Program
March 13, 2019
InMed Pharmaceuticals to Present at the 31st Annual ROTH Conference on March 19, 2019
March 12, 2019
InMed Pharmaceuticals Appoints Dr. Steven M. Dinh to Scientific Advisory Board
March 6, 2019
InMed Pharmaceuticals Reports Second Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update
February 12, 2019
InMed Pharmaceuticals to Report Second Quarter Fiscal 2019 Financial Results and Business Update on February 12, 2019
February 5, 2019
InMed Pharmaceuticals Announces the Appointment of Dr. Sazzad Hossain, PhD, MSc, as a Member of the Scientific Advisory Board and his Retirement as Chief Scientific Officer
January 11, 2019
InMed Pharmaceuticals to Present at Biotech Showcase 2019 on January 9, 2019
January 3, 2019